Get To Know

Kevin Crowley

Senior Managing Director, Investments

Since joining Connecticut Innovations in 2006, Kevin has led investments in Convexity Scientific, Torigen Pharmaceuticals, Affinimark Technologies, Cara Therapeutics (IPO), CaroGen Corporation, Discover Video, HistoRx (sold to Genoptix), Intelligent Clearing Network, Oil Purification Systems, Oxford Performance Materials, Perosphere, Precipio Diagnostics (IPO), Solais Lighting (sold to PowerSecure), MinInvasive Orthopedics Solutions, OmniCyte, VeraDermics, Point Pickup and others. He was on the board of Standing Stone when it was sold to Alere. Kevin is a founding member and on the board of the UConn Innovation Fund, a partnership with Webster Bank, UConn and CI that makes investments in UConn-related technologies.

He managed CI’s $46 million BioFacilities Fund, which invested in wet laboratory space for bioscience companies, and managed CII’s two incubator laboratories in Science Park in New Haven. Kevin was also involved in the establishment of the Connecticut Stem Cell Fund and managed CI’s pre-seed program, which makes investments in very early-stage companies with small convertible-debt instruments.

  • B.S., Management, Quinnipiac University
  • M.B.A., Strategic Planning and Organizational Theory, Quinnipiac University
interesting facts
  • Favorite place: Lake Winnipesaukee, New Hampshire
  • Favorite hobbies: Boating, poker, fishing
  • Favorite food: Guinness
best advice given

“Never be so busy making a living that you don’t make a life.”